$84.98
▲ +0.8% Today
as of Jul 22, 09:19 ET
Last 30 days
Recent Press Releases & News
Morgan Stanley Raises Price Target on Hinge Health to $108 From $72, Keeps Overweight Rating
A Hinge Health Backer Sold $38.4 Million in Stock After a 101% Run
Hinge Health to announce second quarter 2026 financial results on August 4, 2026
Overview
52-week range
$30
$67
100% of range
Avg surprise (last 2)
+10.1%
Avg reaction (last 1)
+1.8%
100% positive
Latest IV / EM
55%
EM ±12.8% · $85 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.34 | $0.12 | +183.3% | — | +1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.02 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-13.10 | $-4.98 | -163.1% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $1.31 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.96 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | $0.28 | -$13.10 | +102.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $182M | — | $154M | $139M | $124M | — | $101M | $90M |
| Cost of revenue | $28M | — | $28M | $41M | $24M | — | $21M | $23M |
| Gross profit | $154M | — | $126M | $98M | $100M | — | $79M | $67M |
| Operating income | $32M | — | $-6M | $-581M | $13M | — | $-4M | $-18M |
| Net income | $35M | — | $-2M | $-576M | $17M | — | $341,000 | $-13M |
| EPS (diluted) | $0.41 | — | $-0.02 | $-13.10 | $1.31 | — | $0.01 | $-0.96 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $187M | $208M | $261M | $237M | $288M | $301M | $268M | $237M |
| Inventory | $14M | $16M | $14M | $14M | — | $11M | — | — |
| Total current assets | $540M | $534M | $659M | $598M | — | $583M | — | — |
| Total assets | $729M | $745M | $770M | $694M | — | $673M | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $417M | $366M | $362M | $320M | — | $257M | — | — |
| Total equity | $112M | $179M | $208M | $174M | $-308M | $-435M | $-462M | $-463M |